nodes	percent_of_prediction	percent_of_DWPC	metapath
Nefazodone—HTR2A—narcolepsy	0.772	1	CbGaD
Nefazodone—SLC6A2—locus ceruleus—narcolepsy	0.015	0.139	CbGeAlD
Nefazodone—HTR2A—enteric nervous system—narcolepsy	0.0136	0.127	CbGeAlD
Nefazodone—HTR2A—locus ceruleus—narcolepsy	0.00899	0.0838	CbGeAlD
Nefazodone—SLC6A2—autonomic nervous system—narcolepsy	0.00795	0.0741	CbGeAlD
Nefazodone—HTR2A—pons—narcolepsy	0.00518	0.0483	CbGeAlD
Nefazodone—HTR2A—autonomic nervous system—narcolepsy	0.00478	0.0445	CbGeAlD
Nefazodone—SLC6A3—brainstem—narcolepsy	0.00238	0.0222	CbGeAlD
Nefazodone—HTR2C—brainstem—narcolepsy	0.0023	0.0214	CbGeAlD
Nefazodone—SLC6A3—forebrain—narcolepsy	0.0023	0.0214	CbGeAlD
Nefazodone—HTR2C—forebrain—narcolepsy	0.00222	0.0207	CbGeAlD
Nefazodone—SLC6A4—brainstem—narcolepsy	0.00218	0.0203	CbGeAlD
Nefazodone—SLC6A4—forebrain—narcolepsy	0.0021	0.0196	CbGeAlD
Nefazodone—HTR1A—brainstem—narcolepsy	0.00194	0.018	CbGeAlD
Nefazodone—SLC6A2—brainstem—narcolepsy	0.00192	0.0179	CbGeAlD
Nefazodone—HTR1A—forebrain—narcolepsy	0.00187	0.0174	CbGeAlD
Nefazodone—SLC6A2—forebrain—narcolepsy	0.00185	0.0173	CbGeAlD
Nefazodone—ADRA1A—brainstem—narcolepsy	0.00178	0.0166	CbGeAlD
Nefazodone—ADRA1A—forebrain—narcolepsy	0.00172	0.016	CbGeAlD
Nefazodone—HTR2C—medulla oblongata—narcolepsy	0.0016	0.0149	CbGeAlD
Nefazodone—SLC6A3—midbrain—narcolepsy	0.00152	0.0141	CbGeAlD
Nefazodone—HTR2C—midbrain—narcolepsy	0.00147	0.0137	CbGeAlD
Nefazodone—SLC6A4—midbrain—narcolepsy	0.00139	0.0129	CbGeAlD
Nefazodone—SLC6A2—medulla oblongata—narcolepsy	0.00134	0.0125	CbGeAlD
Nefazodone—ADRA2A—forebrain—narcolepsy	0.00131	0.0122	CbGeAlD
Nefazodone—ADRA1B—brain—narcolepsy	0.00127	0.0119	CbGeAlD
Nefazodone—HTR1A—midbrain—narcolepsy	0.00123	0.0115	CbGeAlD
Nefazodone—HTR2A—brainstem—narcolepsy	0.00115	0.0107	CbGeAlD
Nefazodone—HTR2A—forebrain—narcolepsy	0.00111	0.0104	CbGeAlD
Nefazodone—CYP2D6—brainstem—narcolepsy	0.00105	0.00979	CbGeAlD
Nefazodone—CYP2D6—forebrain—narcolepsy	0.00101	0.00945	CbGeAlD
Nefazodone—SLC6A3—brain—narcolepsy	0.000953	0.00888	CbGeAlD
Nefazodone—ADRA2A—medulla oblongata—narcolepsy	0.000946	0.00882	CbGeAlD
Nefazodone—HTR2C—brain—narcolepsy	0.000921	0.00858	CbGeAlD
Nefazodone—SLC6A4—brain—narcolepsy	0.000873	0.00814	CbGeAlD
Nefazodone—ADRA2A—midbrain—narcolepsy	0.000865	0.00806	CbGeAlD
Nefazodone—Zuclopenthixol—HTR2A—narcolepsy	0.000843	0.161	CrCbGaD
Nefazodone—HTR2A—medulla oblongata—narcolepsy	0.000805	0.0075	CbGeAlD
Nefazodone—Aripiprazole—HTR2A—narcolepsy	0.000779	0.148	CrCbGaD
Nefazodone—HTR1A—brain—narcolepsy	0.000775	0.00722	CbGeAlD
Nefazodone—Trazodone—HTR2A—narcolepsy	0.000775	0.148	CrCbGaD
Nefazodone—SLC6A2—brain—narcolepsy	0.000769	0.00716	CbGeAlD
Nefazodone—Thioproperazine—HTR2A—narcolepsy	0.000738	0.141	CrCbGaD
Nefazodone—HTR2A—midbrain—narcolepsy	0.000735	0.00685	CbGeAlD
Nefazodone—ABCB1—forebrain—narcolepsy	0.00073	0.0068	CbGeAlD
Nefazodone—ADRA1A—brain—narcolepsy	0.000715	0.00666	CbGeAlD
Nefazodone—Fluphenazine—HTR2A—narcolepsy	0.000628	0.12	CrCbGaD
Nefazodone—ADRA2A—brain—narcolepsy	0.000543	0.00506	CbGeAlD
Nefazodone—ABCB1—medulla oblongata—narcolepsy	0.000527	0.00491	CbGeAlD
Nefazodone—Trifluoperazine—HTR2A—narcolepsy	0.000502	0.0956	CrCbGaD
Nefazodone—Perphenazine—HTR2A—narcolepsy	0.000496	0.0946	CrCbGaD
Nefazodone—Quetiapine—HTR2A—narcolepsy	0.000487	0.0928	CrCbGaD
Nefazodone—ABCB1—midbrain—narcolepsy	0.000482	0.00449	CbGeAlD
Nefazodone—HTR2A—brain—narcolepsy	0.000462	0.0043	CbGeAlD
Nefazodone—CYP2D6—brain—narcolepsy	0.000421	0.00392	CbGeAlD
Nefazodone—ABCB1—brain—narcolepsy	0.000303	0.00282	CbGeAlD
Nefazodone—ADRA1B—GPCR ligand binding—TRH—narcolepsy	0.000198	0.00171	CbGpPWpGaD
Nefazodone—HTR2C—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000198	0.00171	CbGpPWpGaD
Nefazodone—HTR2C—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000198	0.00171	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR ligand binding—PENK—narcolepsy	0.000192	0.00166	CbGpPWpGaD
Nefazodone—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000189	0.00164	CbGpPWpGaD
Nefazodone—ADRA1B—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000189	0.00164	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—HCRTR1—narcolepsy	0.000189	0.00163	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—HCRTR2—narcolepsy	0.000189	0.00163	CbGpPWpGaD
Nefazodone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000188	0.00163	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—HCRTR2—narcolepsy	0.000188	0.00163	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—HCRTR1—narcolepsy	0.000188	0.00163	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—P2RY11—narcolepsy	0.000183	0.00158	CbGpPWpGaD
Nefazodone—HTR1A—GPCR ligand binding—HRH3—narcolepsy	0.000183	0.00158	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—P2RY11—narcolepsy	0.000182	0.00157	CbGpPWpGaD
Nefazodone—HTR2C—GPCR ligand binding—HRH3—narcolepsy	0.000182	0.00157	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—HCRTR2—narcolepsy	0.00018	0.00156	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—HCRTR1—narcolepsy	0.00018	0.00156	CbGpPWpGaD
Nefazodone—HTR2A—GPCR ligand binding—TRH—narcolepsy	0.00018	0.00156	CbGpPWpGaD
Nefazodone—HTR2C—G alpha (q) signalling events—HTR2A—narcolepsy	0.00018	0.00155	CbGpPWpGaD
Nefazodone—ABCB1—Allograft Rejection—HLA-DRB1—narcolepsy	0.000178	0.00154	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR ligand binding—TRH—narcolepsy	0.000176	0.00152	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—P2RY11—narcolepsy	0.000174	0.0015	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR ligand binding—HRH3—narcolepsy	0.000174	0.0015	CbGpPWpGaD
Nefazodone—ADRA1B—G alpha (q) signalling events—HTR2A—narcolepsy	0.000172	0.00149	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—HCRTR1—narcolepsy	0.000172	0.00148	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—HCRTR2—narcolepsy	0.000172	0.00148	CbGpPWpGaD
Nefazodone—HTR2A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000172	0.00148	CbGpPWpGaD
Nefazodone—HTR2A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000172	0.00148	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—HCRTR1—narcolepsy	0.000171	0.00148	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—HCRTR2—narcolepsy	0.000171	0.00148	CbGpPWpGaD
Nefazodone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000168	0.00145	CbGpPWpGaD
Nefazodone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000168	0.00145	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—P2RY11—narcolepsy	0.000166	0.00143	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—P2RY11—narcolepsy	0.000165	0.00143	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR ligand binding—TRH—narcolepsy	0.000164	0.00141	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—HCRTR1—narcolepsy	0.000163	0.00141	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—HCRTR2—narcolepsy	0.000163	0.00141	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—HCRTR1—narcolepsy	0.000163	0.00141	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—HCRTR2—narcolepsy	0.000163	0.00141	CbGpPWpGaD
Nefazodone—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.000161	0.00139	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—HCRTR2—narcolepsy	0.00016	0.00138	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—HCRTR1—narcolepsy	0.00016	0.00138	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—P2RY11—narcolepsy	0.000158	0.00137	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—P2RY11—narcolepsy	0.000158	0.00136	CbGpPWpGaD
Nefazodone—HTR2A—GPCR ligand binding—HRH3—narcolepsy	0.000158	0.00136	CbGpPWpGaD
Nefazodone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000156	0.00135	CbGpPWpGaD
Nefazodone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000156	0.00135	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—HCRT—narcolepsy	0.000155	0.00134	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—P2RY11—narcolepsy	0.000154	0.00134	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—HCRT—narcolepsy	0.000154	0.00134	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR ligand binding—HRH3—narcolepsy	0.000154	0.00134	CbGpPWpGaD
Nefazodone—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.000154	0.00133	CbGpPWpGaD
Nefazodone—ADRA1A—G alpha (q) signalling events—HTR2A—narcolepsy	0.000153	0.00132	CbGpPWpGaD
Nefazodone—HTR1A—GPCR ligand binding—TAC1—narcolepsy	0.000151	0.00131	CbGpPWpGaD
Nefazodone—HTR1A—GPCR ligand binding—NPS—narcolepsy	0.000151	0.00131	CbGpPWpGaD
Nefazodone—HTR2C—GPCR ligand binding—NPS—narcolepsy	0.00015	0.0013	CbGpPWpGaD
Nefazodone—HTR2C—GPCR ligand binding—TAC1—narcolepsy	0.00015	0.0013	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—HCRTR2—narcolepsy	0.000149	0.00128	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—HCRTR1—narcolepsy	0.000149	0.00128	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—HCRTR1—narcolepsy	0.000148	0.00128	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—HCRTR2—narcolepsy	0.000148	0.00128	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—HCRT—narcolepsy	0.000148	0.00128	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—HCRTR1—narcolepsy	0.000145	0.00126	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—HCRTR2—narcolepsy	0.000145	0.00126	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR ligand binding—TAC1—narcolepsy	0.000144	0.00125	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR ligand binding—NPS—narcolepsy	0.000144	0.00125	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—P2RY11—narcolepsy	0.000144	0.00124	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR ligand binding—HRH3—narcolepsy	0.000143	0.00124	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—P2RY11—narcolepsy	0.000143	0.00124	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—HCRT—narcolepsy	0.000141	0.00122	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—HCRT—narcolepsy	0.00014	0.00121	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—P2RY11—narcolepsy	0.00014	0.00121	CbGpPWpGaD
Nefazodone—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000139	0.00121	CbGpPWpGaD
Nefazodone—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000139	0.0012	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—PENK—narcolepsy	0.000138	0.0012	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—PENK—narcolepsy	0.000138	0.00119	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—CHKB—narcolepsy	0.000137	0.00119	CbGpPWpGaD
Nefazodone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.000137	0.00118	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—HCRTR1—narcolepsy	0.000135	0.00117	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—HCRTR2—narcolepsy	0.000135	0.00117	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—HCRT—narcolepsy	0.000134	0.00116	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—HCRT—narcolepsy	0.000134	0.00116	CbGpPWpGaD
Nefazodone—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000133	0.00115	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—PENK—narcolepsy	0.000132	0.00114	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—HCRT—narcolepsy	0.000131	0.00114	CbGpPWpGaD
Nefazodone—HTR2A—GPCR ligand binding—TAC1—narcolepsy	0.000131	0.00113	CbGpPWpGaD
Nefazodone—HTR2A—GPCR ligand binding—NPS—narcolepsy	0.000131	0.00113	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—P2RY11—narcolepsy	0.00013	0.00113	CbGpPWpGaD
Nefazodone—SLC6A4—SIDS Susceptibility Pathways—TNF—narcolepsy	0.000129	0.00111	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR ligand binding—TAC1—narcolepsy	0.000128	0.00111	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR ligand binding—NPS—narcolepsy	0.000128	0.00111	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—PENK—narcolepsy	0.000126	0.00109	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—PENK—narcolepsy	0.000125	0.00108	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—HCRT—narcolepsy	0.000122	0.00106	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—HCRT—narcolepsy	0.000122	0.00105	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—PENK—narcolepsy	0.00012	0.00103	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—PENK—narcolepsy	0.00012	0.00103	CbGpPWpGaD
Nefazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00012	0.00103	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—HCRT—narcolepsy	0.000119	0.00103	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR ligand binding—TAC1—narcolepsy	0.000119	0.00103	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR ligand binding—NPS—narcolepsy	0.000119	0.00103	CbGpPWpGaD
Nefazodone—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000119	0.00103	CbGpPWpGaD
Nefazodone—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000118	0.00102	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—TRH—narcolepsy	0.000118	0.00102	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—PENK—narcolepsy	0.000117	0.00101	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—TRH—narcolepsy	0.000117	0.00101	CbGpPWpGaD
Nefazodone—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000114	0.000984	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—TRH—narcolepsy	0.000112	0.000969	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—HCRT—narcolepsy	0.000111	0.000958	CbGpPWpGaD
Nefazodone—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00011	0.000948	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—PENK—narcolepsy	0.000109	0.00094	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—PENK—narcolepsy	0.000109	0.000939	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—CHKB—narcolepsy	0.000108	0.000936	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—TRH—narcolepsy	0.000107	0.000924	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—PENK—narcolepsy	0.000106	0.000919	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—TRH—narcolepsy	0.000106	0.000919	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—HRH3—narcolepsy	0.000103	0.000892	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—HRH3—narcolepsy	0.000103	0.000887	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—TRH—narcolepsy	0.000102	0.00088	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—TRH—narcolepsy	0.000102	0.000879	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—HCRTR2—narcolepsy	0.000101	0.000877	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—HCRTR1—narcolepsy	0.000101	0.000877	CbGpPWpGaD
Nefazodone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000101	0.000874	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—HCRTR2—narcolepsy	0.000101	0.000872	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—HCRTR1—narcolepsy	0.000101	0.000872	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—TRH—narcolepsy	9.95e-05	0.000861	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—CHKB—narcolepsy	9.92e-05	0.000858	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—PENK—narcolepsy	9.88e-05	0.000854	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—HRH3—narcolepsy	9.82e-05	0.00085	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—P2RY11—narcolepsy	9.79e-05	0.000847	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—P2RY11—narcolepsy	9.74e-05	0.000843	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—HCRTR2—narcolepsy	9.66e-05	0.000835	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—HCRTR1—narcolepsy	9.66e-05	0.000835	CbGpPWpGaD
Nefazodone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	9.39e-05	0.000812	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—HRH3—narcolepsy	9.37e-05	0.00081	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—CPT1B—narcolepsy	9.33e-05	0.000807	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—P2RY11—narcolepsy	9.33e-05	0.000807	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—HRH3—narcolepsy	9.32e-05	0.000806	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—TRH—narcolepsy	9.25e-05	0.0008	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—TRH—narcolepsy	9.23e-05	0.000798	CbGpPWpGaD
Nefazodone—HTR1A—GPCR ligand binding—HTR2A—narcolepsy	9.1e-05	0.000787	CbGpPWpGaD
Nefazodone—HTR2C—GPCR ligand binding—HTR2A—narcolepsy	9.05e-05	0.000783	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—TRH—narcolepsy	9.04e-05	0.000781	CbGpPWpGaD
Nefazodone—HTR1A—SIDS Susceptibility Pathways—TNF—narcolepsy	8.97e-05	0.000776	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—HRH3—narcolepsy	8.92e-05	0.000771	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—HRH3—narcolepsy	8.91e-05	0.000771	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—HCRTR2—narcolepsy	8.76e-05	0.000758	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—HCRTR1—narcolepsy	8.76e-05	0.000758	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—HRH3—narcolepsy	8.73e-05	0.000755	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR ligand binding—HTR2A—narcolepsy	8.67e-05	0.000749	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—HCRTR2—narcolepsy	8.58e-05	0.000742	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—HCRTR1—narcolepsy	8.58e-05	0.000742	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—TAC1—narcolepsy	8.55e-05	0.000739	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—NPS—narcolepsy	8.55e-05	0.000739	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—NPS—narcolepsy	8.5e-05	0.000735	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—TAC1—narcolepsy	8.5e-05	0.000735	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—P2RY11—narcolepsy	8.46e-05	0.000732	CbGpPWpGaD
Nefazodone—ABCB1—Allograft Rejection—TNF—narcolepsy	8.4e-05	0.000727	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—TRH—narcolepsy	8.4e-05	0.000726	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—HCRT—narcolepsy	8.33e-05	0.00072	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—P2RY11—narcolepsy	8.29e-05	0.000716	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—HCRT—narcolepsy	8.29e-05	0.000716	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—NPS—narcolepsy	8.14e-05	0.000704	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—TAC1—narcolepsy	8.14e-05	0.000704	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—HRH3—narcolepsy	8.11e-05	0.000701	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—HRH3—narcolepsy	8.09e-05	0.0007	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—HCRTR1—narcolepsy	7.97e-05	0.000689	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—HCRTR2—narcolepsy	7.97e-05	0.000689	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—HCRT—narcolepsy	7.93e-05	0.000686	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—HRH3—narcolepsy	7.92e-05	0.000685	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—TAC1—narcolepsy	7.76e-05	0.000671	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—NPS—narcolepsy	7.76e-05	0.000671	CbGpPWpGaD
Nefazodone—HTR2A—SIDS Susceptibility Pathways—TNF—narcolepsy	7.75e-05	0.00067	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—NPS—narcolepsy	7.72e-05	0.000668	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—TAC1—narcolepsy	7.72e-05	0.000668	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—P2RY11—narcolepsy	7.7e-05	0.000666	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR ligand binding—HTR2A—narcolepsy	7.7e-05	0.000666	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—CHKB—narcolepsy	7.49e-05	0.000647	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—PENK—narcolepsy	7.42e-05	0.000642	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—NPS—narcolepsy	7.39e-05	0.000639	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—TAC1—narcolepsy	7.39e-05	0.000639	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—NPS—narcolepsy	7.39e-05	0.000639	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—TAC1—narcolepsy	7.39e-05	0.000639	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—PENK—narcolepsy	7.38e-05	0.000639	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—HRH3—narcolepsy	7.36e-05	0.000637	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—CPT1B—narcolepsy	7.36e-05	0.000636	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—TAC1—narcolepsy	7.23e-05	0.000625	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—NPS—narcolepsy	7.23e-05	0.000625	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—HCRT—narcolepsy	7.19e-05	0.000622	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR ligand binding—HTR2A—narcolepsy	7.15e-05	0.000618	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—PENK—narcolepsy	7.07e-05	0.000611	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—CHKB—narcolepsy	7.06e-05	0.00061	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—HCRT—narcolepsy	7.04e-05	0.000609	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—CPT1B—narcolepsy	6.74e-05	0.000583	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—TAC1—narcolepsy	6.72e-05	0.000581	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—NPS—narcolepsy	6.72e-05	0.000581	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—NPS—narcolepsy	6.71e-05	0.00058	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—TAC1—narcolepsy	6.71e-05	0.00058	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—TAC1—narcolepsy	6.57e-05	0.000568	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—NPS—narcolepsy	6.57e-05	0.000568	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—HCRT—narcolepsy	6.55e-05	0.000566	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—PENK—narcolepsy	6.41e-05	0.000554	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—TRH—narcolepsy	6.31e-05	0.000546	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—PENK—narcolepsy	6.28e-05	0.000543	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—TRH—narcolepsy	6.28e-05	0.000543	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—TAC1—narcolepsy	6.1e-05	0.000528	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—NPS—narcolepsy	6.1e-05	0.000528	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—TRH—narcolepsy	6.01e-05	0.00052	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—PENK—narcolepsy	5.83e-05	0.000504	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—HRH3—narcolepsy	5.53e-05	0.000479	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—HRH3—narcolepsy	5.51e-05	0.000476	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—TRH—narcolepsy	5.45e-05	0.000471	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—TRH—narcolepsy	5.34e-05	0.000462	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—HRH3—narcolepsy	5.27e-05	0.000456	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—HTR2A—narcolepsy	5.14e-05	0.000445	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—HTR2A—narcolepsy	5.12e-05	0.000442	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—CPT1B—narcolepsy	5.09e-05	0.00044	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—TRH—narcolepsy	4.96e-05	0.000429	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—HTR2A—narcolepsy	4.9e-05	0.000423	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—CPT1B—narcolepsy	4.8e-05	0.000415	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—HRH3—narcolepsy	4.78e-05	0.000413	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—HRH3—narcolepsy	4.68e-05	0.000405	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—HTR2A—narcolepsy	4.67e-05	0.000404	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—HTR2A—narcolepsy	4.65e-05	0.000402	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CHKB—narcolepsy	4.61e-05	0.000399	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—TAC1—narcolepsy	4.59e-05	0.000397	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—NPS—narcolepsy	4.59e-05	0.000397	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—TAC1—narcolepsy	4.56e-05	0.000394	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—NPS—narcolepsy	4.56e-05	0.000394	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—HTR2A—narcolepsy	4.45e-05	0.000385	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—NPS—narcolepsy	4.37e-05	0.000378	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—TAC1—narcolepsy	4.37e-05	0.000378	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—HTR2A—narcolepsy	4.35e-05	0.000376	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—HRH3—narcolepsy	4.35e-05	0.000376	CbGpPWpGaD
Nefazodone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	4.15e-05	0.000359	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—HTR2A—narcolepsy	4.04e-05	0.000349	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—NPS—narcolepsy	3.96e-05	0.000343	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—TAC1—narcolepsy	3.96e-05	0.000343	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—HTR2A—narcolepsy	3.95e-05	0.000342	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—NPS—narcolepsy	3.88e-05	0.000335	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—TAC1—narcolepsy	3.88e-05	0.000335	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—HTR2A—narcolepsy	3.67e-05	0.000317	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—NPS—narcolepsy	3.6e-05	0.000312	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—TAC1—narcolepsy	3.6e-05	0.000312	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CPT1B—narcolepsy	3.14e-05	0.000271	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—HTR2A—narcolepsy	2.76e-05	0.000239	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—HTR2A—narcolepsy	2.74e-05	0.000237	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—HTR2A—narcolepsy	2.63e-05	0.000227	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—HTR2A—narcolepsy	2.33e-05	0.000202	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—HTR2A—narcolepsy	2.17e-05	0.000187	CbGpPWpGaD
